APEN logo

Apollo Endosurgery (APEN) Depreciation And Amortization

Annual D&A

$2.97 M
-$266.00 K-8.23%

December 31, 2022

Summary

Performance

1-Year Change

-8.23%

3-Year Change

-26.95%

5-Year Change

-69.48%

15-Year Change

-69.48%

APEN Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$9.72 M
APEN annual depreciation & amortization is currently -69.48% below its historical high of $9.72 million

3-Year Low

$2.97 M
APEN annual depreciation & amortization is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
APEN previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
APEN next annual earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$104.68 M
APEN annual total expenses is $104.68 million

Annual Operating Expenses

$70.25 M
APEN annual total operating expenses is $70.25 million

Annual Cost Of Goods Sold

$34.43 M
APEN annual cost of goods sold is $34.43 million

Annual Interest Expense

$4.67 M
APEN annual interest expense is $4.67 million

Quarterly D&A

$719.00 K
-$50.00 K-6.50%

December 31, 2022

Summary

Performance

3-Month Change

-6.5%

1-Year Change

-3.88%

3-Year Change

-24.47%

5-Year Change

-70.74%

APEN Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$8.96 M
APEN quarterly depreciation & amortization is currently -91.97% below its historical high of $8.96 million

3-Year Low

$719.00 K
APEN quarterly depreciation & amortization is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2022
APEN previous earnings announcement was published on Dec 31, 2022

Next Quarterly Earnings Report Date

N/A
APEN next earnings announcement has not yet been scheduled

Related metrics

Quarterly Total Expenses

$29.02 M
APEN quarterly total expenses is $29.02 million

Quarterly Operating Expenses

$19.06 M
APEN quarterly total operating expenses is $19.06 million

Quarterly Cost Of Goods Sold

$9.96 M
APEN quarterly cost of goods sold is $9.96 million

Quarterly Interest Expense

$1.09 M
APEN quarterly interest expense is $1.09 million

TTM D&A

$2.97 M
-$29.00 K-0.97%

December 31, 2022

Summary

Performance

3-Month Change

-0.97%

1-Year Change

-8.23%

3-Year Change

-26.95%

5-Year Change

-26.95%

APEN TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$16.22 M
APEN TTM depreciation & amortization is currently -81.71% below its historical high of $16.22 million

3-Year Low

$2.97 M
APEN TTM depreciation & amortization is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2022
APEN previous earnings announcement was published on Dec 31, 2022

Next Quarterly Earnings Report Date

N/A
APEN next earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$104.68 M
APEN annual total expenses is $104.68 million

Annual Operating Expenses

$70.25 M
APEN annual total operating expenses is $70.25 million

TTM Cost Of Goods Sold

$34.43 M
APEN TTM cost of goods sold is $34.43 million

TTM Interest Expense

$4.67 M
APEN TTM interest expense is $4.67 million

APEN Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-8.2%-3.9%-8.2%
3 y3 years-26.9%-24.5%-26.9%
5 y5 years-69.5%-70.7%-26.9%

APEN Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-8.2%at low-6.5%at low-8.2%at low
5 y5-year-26.9%at low-24.7%at low-26.9%at low
alltimeall time-69.5%-98.3%-92.0%-174.7%-81.7%-101.8%

Apollo Endosurgery Depreciation And Amortization History

DateAnnualQuarterlyTTM
Dec 2022
$2.97 M(-8.2%)
$719.00 K(-6.5%)
$2.97 M(-1.0%)
Sep 2022
-
$769.00 K(+4.3%)
$3.00 M(+0.6%)
Jun 2022
-
$737.00 K(-0.5%)
$2.98 M(-3.0%)
Mar 2022
-
$741.00 K(-0.9%)
$3.07 M(-5.0%)
Dec 2021
$3.23 M(-13.4%)
$748.00 K(-0.5%)
$3.23 M(-4.8%)
Sep 2021
-
$752.00 K(-9.2%)
$3.39 M(-4.7%)
Jun 2021
-
$828.00 K(-8.4%)
$3.56 M(-3.2%)
Mar 2021
-
$904.00 K(-0.7%)
$3.68 M(-1.4%)
Dec 2020
$3.73 M(-8.1%)
$910.00 K(-1.2%)
$3.73 M(-1.1%)
Sep 2020
-
$921.00 K(-2.4%)
$3.77 M(-0.9%)
Jun 2020
-
$944.00 K(-1.2%)
$3.81 M(-2.7%)
Mar 2020
-
$955.00 K(+0.3%)
$3.91 M(-3.7%)
Dec 2019
$4.06 M(-56.3%)
$952.00 K(-0.4%)
$4.06 M(-24.5%)
Sep 2019
-
$956.00 K(-8.8%)
$5.38 M(-20.4%)
Jun 2019
-
$1.05 M(-5.1%)
$6.76 M(-15.9%)
Mar 2019
-
$1.10 M(-51.3%)
$8.04 M(-13.5%)
Dec 2018
$9.29 M(-4.4%)
$2.27 M(-3.0%)
$9.29 M(-2.0%)
Sep 2018
-
$2.34 M(+0.3%)
$9.48 M(-0.5%)
Jun 2018
-
$2.33 M(-1.2%)
$9.53 M(-1.5%)
Mar 2018
-
$2.36 M(-4.0%)
$9.68 M(-0.4%)
Dec 2017
$9.72 M(+6.9%)
$2.46 M(+3.1%)
$9.72 M(-40.1%)
Sep 2017
-
$2.38 M(-3.8%)
$16.22 M(+22.0%)
Jun 2017
-
$2.48 M(+3.3%)
$13.30 M(+16.2%)
Mar 2017
-
$2.40 M(-73.2%)
$11.45 M(+25.9%)
Dec 2016
$9.09 M(+1846.9%)
$8.96 M(-1767.3%)
$9.09 M(+2575.7%)
Sep 2016
-
-$537.20 K(-185.7%)
$339.80 K(-65.9%)
Jun 2016
-
$626.90 K(+1280.8%)
$996.90 K(+125.6%)
Mar 2016
-
$45.40 K(-77.8%)
$441.80 K(-5.4%)
Dec 2015
$467.00 K(+116.1%)
$204.70 K(+70.7%)
$467.00 K(+50.0%)
Sep 2015
-
$119.90 K(+67.0%)
$311.40 K(+20.0%)
Jun 2015
-
$71.80 K(+1.7%)
$259.50 K(+3.5%)
Mar 2015
-
$70.60 K(+43.8%)
$250.70 K(+16.1%)
Dec 2014
$216.10 K(+10.1%)
$49.10 K(-27.8%)
$216.00 K(+7.1%)
Sep 2014
-
$68.00 K(+7.9%)
$201.70 K(+21.4%)
Jun 2014
-
$63.00 K(+75.5%)
$166.10 K(-12.6%)
Mar 2014
-
$35.90 K(+3.2%)
$190.10 K(-3.1%)
DateAnnualQuarterlyTTM
Dec 2013
$196.20 K(+4.6%)
$34.80 K(+7.4%)
$196.20 K(-28.4%)
Sep 2013
-
$32.40 K(-62.8%)
$273.90 K(+1.7%)
Jun 2013
-
$87.00 K(+107.1%)
$269.30 K(+29.5%)
Mar 2013
-
$42.00 K(-62.7%)
$207.90 K(+10.9%)
Dec 2012
$187.50 K(+32.0%)
$112.50 K(+304.7%)
$187.40 K(+24.0%)
Sep 2012
-
$27.80 K(+8.6%)
$151.10 K(-0.5%)
Jun 2012
-
$25.60 K(+19.1%)
$151.80 K(+6.9%)
Mar 2012
-
$21.50 K(-71.8%)
$142.00 K(+0.1%)
Dec 2011
$142.00 K(-14.1%)
$76.20 K(+167.4%)
$141.90 K(+16.9%)
Sep 2011
-
$28.50 K(+80.4%)
$121.40 K(-3.2%)
Jun 2011
-
$15.80 K(-26.2%)
$125.40 K(-15.2%)
Mar 2011
-
$21.40 K(-61.6%)
$147.80 K(-10.6%)
Dec 2010
$165.30 K(-6.5%)
$55.70 K(+71.4%)
$165.30 K(+0.4%)
Sep 2010
-
$32.50 K(-14.9%)
$164.70 K(-5.7%)
Jun 2010
-
$38.20 K(-1.8%)
$174.70 K(-1.0%)
Mar 2010
-
$38.90 K(-29.4%)
$176.40 K(-0.2%)
Dec 2009
$176.70 K(+13.0%)
$55.10 K(+29.6%)
$176.70 K(-424.8%)
Sep 2009
-
$42.50 K(+6.5%)
-$54.40 K(-4284.6%)
Jun 2009
-
$39.90 K(+1.8%)
$1300.00(+225.0%)
Mar 2009
-
$39.20 K(-122.3%)
$400.00(>+9900.0%)
Dec 2008
-
-$176.00 K(-279.2%)
$0.00(-100.0%)
Sep 2008
-
$98.20 K(+151.8%)
$206.70 K(+17.5%)
Jun 2008
-
$39.00 K(+0.5%)
$175.90 K(+1.2%)
Mar 2008
-
$38.80 K(+26.4%)
$173.90 K(+11.2%)
Dec 2007
$156.40 K(+215.3%)
$30.70 K(-54.5%)
$156.40 K(+9.6%)
Sep 2007
-
$67.40 K(+82.2%)
$142.70 K(+62.2%)
Jun 2007
-
$37.00 K(+73.7%)
$88.00 K(+42.4%)
Mar 2007
-
$21.30 K(+25.3%)
$61.80 K(+24.8%)
Dec 2006
$49.60 K(-38.9%)
$17.00 K(+33.9%)
$49.50 K(-1.2%)
Sep 2006
-
$12.70 K(+17.6%)
$50.10 K(-33.6%)
Jun 2006
-
$10.80 K(+20.0%)
$75.50 K(+2.3%)
Mar 2006
-
$9000.00(-48.9%)
$73.80 K(-9.1%)
Dec 2005
$81.20 K
$17.60 K(-53.8%)
$81.20 K(+27.7%)
Sep 2005
-
$38.10 K(+318.7%)
$63.60 K(+149.4%)
Jun 2005
-
$9100.00(-44.5%)
$25.50 K(+55.5%)
Mar 2005
-
$16.40 K
$16.40 K

FAQ

  • What is Apollo Endosurgery annual depreciation & amortization?
  • What is the all time high annual D&A for Apollo Endosurgery?
  • What is Apollo Endosurgery annual D&A year-on-year change?
  • What is Apollo Endosurgery quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Apollo Endosurgery?
  • What is Apollo Endosurgery quarterly D&A year-on-year change?
  • What is Apollo Endosurgery TTM depreciation & amortization?
  • What is the all time high TTM D&A for Apollo Endosurgery?
  • What is Apollo Endosurgery TTM D&A year-on-year change?

What is Apollo Endosurgery annual depreciation & amortization?

The current annual D&A of APEN is $2.97 M

What is the all time high annual D&A for Apollo Endosurgery?

Apollo Endosurgery all-time high annual depreciation & amortization is $9.72 M

What is Apollo Endosurgery annual D&A year-on-year change?

Over the past year, APEN annual depreciation & amortization has changed by -$266.00 K (-8.23%)

What is Apollo Endosurgery quarterly depreciation & amortization?

The current quarterly D&A of APEN is $719.00 K

What is the all time high quarterly D&A for Apollo Endosurgery?

Apollo Endosurgery all-time high quarterly depreciation & amortization is $8.96 M

What is Apollo Endosurgery quarterly D&A year-on-year change?

Over the past year, APEN quarterly depreciation & amortization has changed by -$29.00 K (-3.88%)

What is Apollo Endosurgery TTM depreciation & amortization?

The current TTM D&A of APEN is $2.97 M

What is the all time high TTM D&A for Apollo Endosurgery?

Apollo Endosurgery all-time high TTM depreciation & amortization is $16.22 M

What is Apollo Endosurgery TTM D&A year-on-year change?

Over the past year, APEN TTM depreciation & amortization has changed by -$266.00 K (-8.23%)